Commonly reported side effects of ado-trastuzumab emtansine include: increased serum bilirubin, increased serum transaminases, cough, decreased platelet count, dyspnea, fatigue, fever, peripheral neuropathy, and thrombocytopenia. Other side effects include: chills.  See below for a comprehensive list of adverse effects.
The most frequently reported side effects included nausea, fatigue, musculoskeletal pain, thrombocytopenia, increased transaminases, headache, and constipation.
Common (1% to 10%): Hypertension (5.1%), left ventricular dysfunction (1.8%)
Very common (10% or more): Rash (11.6%)Common (1% to 10%): Pruritus (5.5%)
Very common (10% or more): Nausea (39.8%), constipation (26.5%), diarrhea (24.1%), vomiting (19.2%), abdominal pain (18.6%), dry mouth (16.7%), stomatitis (14.1%)Common (1% to 10%): Dyspepsia (9.2%)
Common (1% to 10%): Urinary tract infection (9.4%)
Very common (10% or more): Decreased platelet count (83%), decreased hemoglobin (60%), decreased neutrophils (39%), thrombocytopenia (31.2%), anemia (14.2%)Common (1% to 10%): Neutropenia (6.7%)
Very common (10% or more): Increased AST (98%), increased ALT (82%), increased transaminases (28.8%), increased bilirubin (17%)Uncommon (0.1% to 1%): Nodular regenerative hyperplasia (0.4%), portal hypertension (0.4%)
Common (1% to 10%): Drug hypersensitivity (2.2%)
Common (1% to 10%): Positive test for anti-ado-trastuzumab emtansine antibodies (5.3%)
Very common (10% or more): Decreased potassium (33%), hypokalemia (10.2%)Common (1% to 10%): Alkaline phosphatase increased (4.7%)
Very common (10% or more): Musculoskeletal pain (36.1%), arthralgia (19.2%), myalgia (14.1%)
Very common (10% or more): Headache (28.2%), peripheral neuropathy (21.2%), dizziness (10.2%)Common (1% to 10%): Dysgeusia (8.0%)
Common (1% to 10%): Vision blurred (4.5%), dry eye (3.9%), conjunctivitis (3.9%), lacrimation increased (3.3%)
Very common (10% or more): Fatigue (36.3%), pyrexia (18.6%), asthenia (17.8%)Common (1% to 10%): Chills (7.6%), peripheral edema (7.1%), infusion related reaction (1.4%)
Very common (10% or more): Insomnia (12.0%)
Very common (10% or more): Epistaxis (22.5%), cough (18.2%), dyspnea (12.0%), Common (1% to 10%): Pneumonitis (1.2%)
Black, tarry stools
bladder pain
bleeding gums
bloating or swelling of the face, arms, hands, lower legs, or feet
bloody or cloudy urine
blurred vision
burning, numbness, tingling, or painful sensations
chills
convulsions
cough
decreased urine
difficult or labored breathing
difficult, burning, or painful urination
dizziness
dry mouth
fever
frequent urge to urinate
headache
increased thirst
irregular heartbeat
loss of appetite
lower back or side pain
mood changes
muscle pain or cramps
nausea or vomiting
nervousness
nosebleeds
numbness or tingling in the hands, feet, or lips
pale skin
pinpoint red spots on the skin
pounding in the ears
rapid weight gain
slow or fast heartbeat
sore throat
tightness in the chest
troubled breathing with exertion
ulcers, sores, or white spots in the mouth
unsteadiness or awkwardness
unusual bleeding or bruising
unusual tiredness or weakness
unusual weight gain or loss
weakness in the arms, hands, legs, or feet
Chest pain
dilated neck veins
extreme fatigue
general feeling of discomfort or illness
irregular breathing
irregular heartbeat
skin rash
thickening of bronchial secretions
Dark-colored urine
general feeling of tiredness or weakness
light-colored stools
stomach bloating or pain
vomiting blood
yellow eyes or skin
Abdominal or stomach tenderness
itching
Acid or sour stomach
belching
change in taste
constipation
diarrhea
difficulty with moving
heartburn
indigestion
lack or loss of strength
loss of taste
muscle pain or stiffness
pain in the joints
stomach discomfort or upset
swelling or inflammation of the mouth
trouble sleeping
Burning, dry, or itching eyes
discharge or excessive tearing
redness, pain, or swelling of the eye, eyelid, or inner lining of the eyelid